National and Kapodistrian University of Athens
Η ανεμευλογιά ως αίτιο συνύπαρξης αυτοάνοσων νοσημάτων σε παιδιά με ινσουλινοεξαρτώμενο σακχαρώδη διαβήτη
Abstract
dc:descriptionT1DM is a chronic autoimmune disease, characterized by destruction of insulin-producing pancreatic beta-cells, and the presence of autoantibodies against beta-cells. Such autoimmune aggression however is not limited to the pancreas, but also affects other endocrine (thyroid gland, adrenal tissue) and non endocrine tissues (gastrointestinal mucosa). The associated autoimmunity has a major effect on diabetic control by impairing function of the affected organ. The most common autoimmune disease between children with T1DM is thyroid autoimmunity (TAI). TAI is characterised by autoantibody production against thyroid gland, T- lymphocytic infiltration and subsequent thyroid gland dysfunction, leading to the clinical manifestation of hyperthyroidism or hypothyroidism. The range of the reported prevalence of TAI in children with T1DM is usually wide and varies from 3.4% up to 20%. The difference of the TAI prevalence in the bibliography can be attributed to the fact that many factors influence the presence of TAI in children with T1DM. It is widely accepted that TAI is related to the race, the age of diabetes onset, and the duration of diabetes and is more frequent in girls (girls/boys: 2:1). Increased risk for the manifestation of TAI appears to have also the children of Caucasian ethnicity. An increased prevalence of celiac disease (CD) has been found in children and adolescents with T1DM, compared with non-diabetic population. The prevalence of CD varies in different geographical populations and ranges from 3-8%. The association between CD and T1DM can be attributed to a common genetic background or to the fact that long-term exposure to gluten can induce T1DM and other autoimmune disorders to genetically predisposed people. The likelihood of CD being diagnosed in children with T1DM increases with the duration of diabetes, the female sex, the presence of thyroid autoimmunity and the age of diabetes onset. Gastric and adrenal autoimmunity are not very frequent among diabetic patients. The prevalence of parietal cell autoantibodies (PCA) ranges from 5-20% and of adrenal gland autoantibodies (AAA) ranges from 0,8-2% in diabetic patients. Addison’s disease has been described in association with T1DM mainly as a part of autoimmune polyendocrine syndrome type II (APS type 2), while the most frequent co-occurrence between autoimmune diseases is that between autoimmune thyroiditis, T1DM and autoimmune gastritis (APS type 3). The aims of our study were: 1. The estimation of the prevalence of children and adolescents with T1DM and multiple autoimmunity, and their clinical characteristics. 2. The effect of multiple autoimmunity on different factors [age, gender, duration of diabetes, age at onset and BMIJ and on the normal glucaemic control. 3. The effect of multiple autoimmunity on clinical manifestations of the children and adolescents with T1DM 4. The relationship and co-existence between different autoimmune disorders. The study population consisted of 144 (male/female: 77/67) children and adolescents with T1DM, followed in our outpatients’ Diabetic Clinic. The mean age (±SD) age of the patients was 12.3±4.6 years, with a mean age at T1DM diagnosis of 7.7±3.6 years and a mean diabetes duration of 4.6±3.9 years. The study was approved by the local Ethical Committee. Informed consent was obtained from each patient and/or parent before blood sampling. In our study group, 17 children with DM1 (11.8%) expressed multiple autoimmunity. Among these children, 12/144 (8.3%) showed positive GADA and one other organ-specific autoantibody. 10 were positive for GADA and thyroid autoantibodies, two were positive for both GADA and anti-tTG. Five children (5/144, 3.5%) were found with GADA and two other organ-specific autoantibodies positive. Four of them were positive for GADA, thyroid autoantibodies and APCA, while only one child was positive for GADA, thyroid autoantibodies and anti-tTG. Children with GADA and thyrogastric autoimmunity (4 children, 3 males/1 female) had mean age of 13.7 years (range: 8.7-17.5 years), mean age at diabetes diagnosis 6.4 years (range: 4.9-10.4 years) and mean duration of diabetes 7.3 years (range: 3.8-7.1 years). They initially became positive for thyroid autoantibodies at a mean age of 8.5 years old (range 6.1-10.4 years) and were submitted to L-thyroxin treatment at a mean age of 11.5 years (range: 7.5-14.0 years). Except from APCA positivity, these children did not manifest any clinical symptom of gastric autoimmunity or anemia. The child with positive GADA, anti-tTG and thyroid autoantibodies was a 7.8 years old boy, who was diagnosed for diabetes at the age of 4.7 years old. This child developed thyroiditis at the age of 6 years and celiac disease (confirmed with small bowel biopsy) at the age of 7.2 years. His body weigh was below normal values (BMI: 15.5 kg/m2), but his height was normal (height SDS: +0.2). When comparing the group of patients with multiple autoimmunity with the rest of the study group (table 15), no significant difference in terms of age, gender, age at diabetes diagnosis, diabetes duration, BMI or growth status was observed. However the children with multiple autoimmunity had poorer glycaemic control (HbA1c: 9.0% vs 8.0%, p=0.049). When comparing the three groups of children with: a) 0 or 1 antibody positivity, b) GADA and one additional autoantibody, c) GADA and two additional autoantibodies positive, no significant difference was observed in terms of current age, age at diabetes diagnosis, BMI, growth, or glycaemic control. Nevertheless we observed a gradual increase in TSH levels, with the lower levels in group a and the higher levels in the group c with multiple autoimmunity (TSH: 2.6 vs 3.0 vs 5.0 μU/ml, p=0.046). Logistic regression analysis showed that only the presence of APCA was determined by ATPO and TG positivity. Specifically the risk for positive APCA in children with DM1 was 17-20 folds higher in children with positive thyroid autoantibodies. Thus the above observations indicate that, in children with T1DM, the identification of anti-GAD could be used as a predictor for the possible development of thyroid or gastric autoimmunity and that anti-GAD-positive diabetic children may need a closer follow-up of their autoimmunity status. Conversely, the presence of celiac autoimmunity in our study was not associated with the presence of anti-GAD, confirming previous reports (DeBlock).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kakleas, Konstantinos
- Κακλέας, Κωνσταντίνος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18461